These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 23500543

  • 1. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF, Schiedel AC, Thimm D, Hinz S, Sherbiny FF, Müller CE.
    Biochem Pharmacol; 2013 May 01; 85(9):1317-29. PubMed ID: 23500543
    [Abstract] [Full Text] [Related]

  • 2. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D, Schiedel AC, Sherbiny FF, Hinz S, Hochheiser K, Bertarelli DC, Maass A, Müller CE.
    Biochemistry; 2013 Jan 29; 52(4):726-40. PubMed ID: 23286920
    [Abstract] [Full Text] [Related]

  • 3. A2A and A2B adenosine receptors: The extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosine.
    De Filippo E, Hinz S, Pellizzari V, Deganutti G, El-Tayeb A, Navarro G, Franco R, Moro S, Schiedel AC, Müller CE.
    Biochem Pharmacol; 2020 Feb 29; 172():113718. PubMed ID: 31751537
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S, Lacher SK, Seibt BF, Müller CE.
    J Pharmacol Exp Ther; 2014 Jun 29; 349(3):427-36. PubMed ID: 24633424
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.
    Alnouri MW, Jepards S, Casari A, Schiedel AC, Hinz S, Müller CE.
    Purinergic Signal; 2015 Sep 29; 11(3):389-407. PubMed ID: 26126429
    [Abstract] [Full Text] [Related]

  • 9. Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.
    Lebon G, Edwards PC, Leslie AG, Tate CG.
    Mol Pharmacol; 2015 Jun 29; 87(6):907-15. PubMed ID: 25762024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA, Chuo CH, Baltos JA, Ford L, Scammells PJ, Wang BH, Christopoulos A, White PJ, May LT.
    Biochem Pharmacol; 2016 Oct 01; 117():46-56. PubMed ID: 27520486
    [Abstract] [Full Text] [Related]

  • 12. Domains for activation and inactivation in G protein-coupled receptors--a mutational analysis of constitutive activity of the adenosine A2B receptor.
    Peeters MC, Li Q, Elands R, van Westen GJ, Lenselink EB, Müller CE, IJzerman AP.
    Biochem Pharmacol; 2014 Nov 15; 92(2):348-57. PubMed ID: 25179146
    [Abstract] [Full Text] [Related]

  • 13. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
    Peeters MC, van Westen GJ, Guo D, Wisse LE, Müller CE, Beukers MW, Ijzerman AP.
    FASEB J; 2011 Feb 15; 25(2):632-43. PubMed ID: 21030693
    [Abstract] [Full Text] [Related]

  • 14. Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.
    Wolska N, Rozalski M.
    Int J Mol Sci; 2019 Nov 03; 20(21):. PubMed ID: 31684173
    [Abstract] [Full Text] [Related]

  • 15. Activation of adenosine A2A or A2B receptors causes hypothermia in mice.
    Carlin JL, Jain S, Duroux R, Suresh RR, Xiao C, Auchampach JA, Jacobson KA, Gavrilova O, Reitman ML.
    Neuropharmacology; 2018 Sep 01; 139():268-278. PubMed ID: 29548686
    [Abstract] [Full Text] [Related]

  • 16. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D, Gao ZG, Moss SM, Jacobson KA, Carlsson J.
    J Chem Inf Model; 2015 Mar 23; 55(3):550-63. PubMed ID: 25625646
    [Abstract] [Full Text] [Related]

  • 17. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA, Tan CY, Gregory KJ, Christopoulos A, White PJ, May LT.
    J Pharmacol Exp Ther; 2016 Apr 23; 357(1):36-44. PubMed ID: 26791603
    [Abstract] [Full Text] [Related]

  • 18. On the G protein-coupling selectivity of the native A2B adenosine receptor.
    Gao ZG, Inoue A, Jacobson KA.
    Biochem Pharmacol; 2018 May 23; 151():201-213. PubMed ID: 29225130
    [Abstract] [Full Text] [Related]

  • 19. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
    Rodríguez D, Piñeiro Á, Gutiérrez-de-Terán H.
    Biochemistry; 2011 May 17; 50(19):4194-208. PubMed ID: 21480628
    [Abstract] [Full Text] [Related]

  • 20. Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism.
    Baltos JA, Vecchio EA, Harris MA, Qin CX, Ritchie RH, Christopoulos A, White PJ, May LT.
    Biochem Pharmacol; 2017 Jul 01; 135():79-89. PubMed ID: 28344125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.